These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8871619)

  • 41. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands.
    Lal RB; Rudolph DL; Dezzutti CS; Linsley PS; Prince HE
    J Immunol; 1996 Aug; 157(3):1288-96. PubMed ID: 8757637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    Korngold R; Sprent J
    J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antilymphocytic antibodies and bone marrow transplantation. XI. Evidence that reduced Thy-1 expression in Thy-1.1 mice prevents suppression of graft-versus-host disease with anti-Thy-1 monoclonal antibodies.
    Mysliwietz J; Thierfelder S; Hoffmann-Fezer G; Kummer U
    Transplantation; 1990 Apr; 49(4):749-55. PubMed ID: 1970200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
    Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA
    J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intercellular adhesion molecule-1 is necessary but not sufficient to activate CD4+ T cells. Discovery of a novel costimulator on kidney tubule cells.
    Hagerty DT
    J Immunol; 1996 May; 156(10):3652-9. PubMed ID: 8621899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Locally administered monoclonal antibodies to lymphocyte function-associated antigen 1 and to L3T4 prevent cutaneous graft-vs-host disease.
    Shiohara T; Moriya N; Gotoh C; Saizawa K; Nagashima M
    J Immunol; 1988 Oct; 141(7):2261-7. PubMed ID: 3049803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity.
    Reiser H; Schneeberger EE
    Eur J Immunol; 1996 Apr; 26(4):880-5. PubMed ID: 8625983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a coordinated CD8 and CD4 T cell response directed against mismatched HLA Class I causing severe acute graft-versus-host disease.
    Amir AL; Hagedoorn RS; van Luxemburg-Heijs SA; Marijt EW; Kruisselbrink AB; Frederik Falkenburg JH; Heemskerk MH
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):210-9. PubMed ID: 22015995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
    Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
    Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
    Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
    Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eliminating graft-versus-host potential from T cell immunotherapeutic populations.
    Rencher SD; Houston JA; Lockey TD; Hurwitz JL
    Bone Marrow Transplant; 1996 Aug; 18(2):415-20. PubMed ID: 8864455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
    Duramad O; Laysang A; Li J; Ishii Y; Namikawa R
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
    Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Major histocompatibility complex class II expression is required for posttransplant immunological but not hemopoietic reconstitution in mice.
    Huss R; Beckham C; Storb R; Deeg HJ
    Transplantation; 1994 Dec; 58(12):1366-71. PubMed ID: 7809930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
    Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
    Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Vallera DA
    Blood; 1995 May; 85(9):2607-18. PubMed ID: 7537122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Signaling by a new anti-Thy 1 monoclonal antibody inhibits T cell proliferation and interferes with T-cell-mediated induction of costimulatory molecule B7-2.
    Wu Y; Guo Y; Janeway CA; Liu Y
    Cell Immunol; 1995 Oct; 165(2):266-77. PubMed ID: 7553891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies.
    Hasbold J; Johnson-Léger C; Atkins CJ; Clark EA; Klaus GG
    Eur J Immunol; 1994 Aug; 24(8):1835-42. PubMed ID: 7519998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved survival from potentially lethal graft-vs.-host disease by donor pretreatment with a recipient-specific blood transfusion. II. Evidence for a principal role of the CD4+ T cell subset.
    Knulst AC; Tibbe GJ; Bril-Bazuin C; Benner R
    Eur J Immunol; 1993 Jan; 23(1):299-302. PubMed ID: 8093444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.